ArticleThe British journal of radiology2023
Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification.
Article in The British journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Precision Risk Stratification in Prostate Cancer: Unveiling MRI-Based Habitat-Driven Radiomics Model for Enhanced Treatment Guidance.Journal of imaging informatics in medicine · 2026Article
- Interpretable machine learning model of contrast-enhanced CT radiomics for predicting post-BCG recurrence in high-grade non-muscle-invasive bladder cancer.World journal of urology · 2026Article
- Prioritising Data Quality Governance for AI in Prostate Cancer: A Methodological Proof-of-Concept Study Using Neural Networks for Risk Stratification.Diagnostics (Basel, Switzerland) · 2026Article
- Role of urinary leukocytes in the risk stratification of prostate cancer using nonlinear stacking learning strategy: a bi-cohort diagnostic study.Frontiers in oncology · 2026Article
- Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications.Journal of imaging · 2025Review
- Artificial Intelligence Across the Prostate Cancer Pathway: Screening, Imaging, Pathology, and Biomarkers.Cureus · 2025Review
- Beyond Radiomics Alone: Enhancing Prostate Cancer Classification with ADC Ratio in a Multicenter Benchmarking Study.Diagnostics (Basel, Switzerland) · 2025Article
- The Role of Radiomic Analysis and Different Machine Learning Models in Prostate Cancer Diagnosis.Journal of imaging · 2025Article
- Federated multimodal AI for precision-equitable diabetes care.Frontiers in digital health · 2025Review
- Tumour habitat-based radiomics analysis enhances the ability to predict prostate cancer aggressiveness with biparametric MRI-derived features.Frontiers in oncology · 2025Article
- Clinical-radiomics hybrid modeling outperforms conventional models: machine learning enhances stratification of adverse prognostic features in prostate cancer.Frontiers in oncology · 2025Article
- Utilization of artificial intelligence in prostate cancer detection: a comprehensive review of innovations in screening and diagnosis.Frontiers in immunology · 2025Review
- Article
- Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction.Cancers · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo precisely predict prostate cancer (PCa) risk stratification, we constructed a machine learning (ML) model based on magnetic resonance imaging (MRI) radiomic features.
methodsBetween August 2016 and May 2021, patients with histologically proven PCa who underwent pre-operative MRI and prostate-specific antigen screening were included. The patients were grouped into different risk categories as defined by the European Association of Urology-European Association of Nuclear Medicine-European Society for Radiotherapy and Oncology-European Society of Urogenital Radiology-International Society of Geriatric Oncology guidelines. Using Artificial Intelligence Kit software, PCa regions of interest were delineated and radiomic features were extracted. Subsequently, predictable models were built by utilising five traditional ML approaches: support vector machine, logistic regression, gradient boosting decision tree, k-nearest neighbour and random forest (RF) classifiers. The classification capacity of the developed models was assessed by area under the receiver operating characteristic curve (AUC) analysis.
resultsA total of 213 patients were enrolled, including 16 low-risk, 65 intermediate-risk, and 132 high-risk PCa patients. The risk stratification of PCa could be revealed by MRI radiomic features, and second-order features accounted for most of the selected features. Among the five established ML models, the RF model showed the best overall predictive performance (AUC = 0.87). After further analysis of the subgroups based on the RF model, the prediction of the high-risk group was the best (AUC = 0.89).
conclusionThis study demonstrated that the MR radiomics-based ML method could be a promising tool for predicting PCa risk stratification precisely. ADVANCES IN KNOWLEDGE: The ML models have valuable prospect for accurate PCa risk assessment, which might contribute to customize treatment and surveillance strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.